Variable Clinical Phenotypes and Relation of Interferon Signature with Disease Activity in ADA2 Deficiency.
J Rheumatol
; 46(5): 523-526, 2019 05.
Article
en En
| MEDLINE
| ID: mdl-30647181
OBJECTIVE: An upregulation of type I interferon (IFN) stimulated genes [IFN score (IS)] was described in patients with adenosine deaminase 2 deficiency (DADA2). We describe the clinical course of 5 such patients and the role of IS as a marker of disease activity and severity. METHODS: Expression levels of IS were determined by quantitative real-time PCR. RESULTS: Five white patients were identified as carrying CECR1 mutations. The IS before treatment was elevated in 4 out of 5 patients and decreased after treatment. CONCLUSION: Our data confirm the high variability of DADA2 and suggest type I IS as a biomarker of disease activity.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Adenosina Desaminasa
/
Interferones
/
Inmunodeficiencia Combinada Grave
/
Predisposición Genética a la Enfermedad
/
Agammaglobulinemia
/
Péptidos y Proteínas de Señalización Intercelular
/
Transcriptoma
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
País/Región como asunto:
Europa
Idioma:
En
Revista:
J Rheumatol
Año:
2019
Tipo del documento:
Article